LONDON--(BUSINESS WIRE)--Jan. 10, 2006--Stellar Pharmaceuticals Inc. ("Stellar") (TSX VENTURE:SLX)(OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported signing a licensing agreement with Al-Mohab Trading & Contracting Co. ("Al-Mohab") for NeoVisc(R) in Kuwait. Al-Mohab is a Kuwait company involved in the marketing and distribution of medical and hospital supplies.
